NextPlat (NXPL) Acquisitions (2015 - 2023)
NextPlat's (NXPL) quarterly Acquisitions came in at -$183.0 in Q4 2023, down 100.0% quarter-over-quarter from $7.4 million in Q3 2023.
Powered by 
Analysis
NextPlat (NXPL) Acquisitions (2015 - 2023) Analysis & Trends
NextPlat (NXPL) has reported Acquisitions for 2 consecutive years, with -$183.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Acquisitions changed N/A year-over-year to -$183.0 in Q4 2023; TTM through Sep 2025 was -$183.0, a 100.0% decrease from a year earlier, with the FY2024 full-year figure at $1.1 million, down 85.12% from the prior year.
- Acquisitions was -$183.0 for Q4 2023 at NextPlat, down from $7.4 million in the prior quarter.
- Over five years, Acquisitions peaked at $7.4 million in Q3 2023 and troughed at -$183.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -2.32 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -183.00 |
| Sep 30, 2023 | 7.35 Mn |
| Mar 31, 2015 | 30,934.00 |